| Log in

Diagnostics biz can easily sustain 16-18% annual growth in long term: SRL CEO

06 October, 2016

In August, Fortis Healthcare said its board has approved a restructuring plan that would see its diagnostics business being spun out into a separate listed company without going th ....

To read the Full Story

Covering India’s Investment Ecosystem

subscribe

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
How former SRL CEO Sanjeev Vashishta aims to build Mankind's diagnostics biz

How former SRL CEO Sanjeev Vashishta aims to build Mankind’s diagnostics biz

Joseph Rai 7 months ago
Pathkind Diagnostics Pvt. Ltd will bet on an organic growth strategy and tap...
Mankind Pharma picks industry veteran for diagnostics biz float

Mankind Pharma picks industry veteran for diagnostics biz float

Joseph Rai 8 months ago
Drugmaker Mankind Pharma Ltd is entering the diagnostics business and has picked...
Fortis controlled diagnostics chain SRL to list via reverse merger with group firm

Fortis controlled diagnostics chain SRL to list via reverse merger with group firm

Joseph Rai 1 year ago
Fortis Healthcare Ltd said on Friday its board has approved a restructuring plan...
No Comments

Diagnostics biz can easily sustain 16-18% annual growth in long term: SRL CEO

Powered by WordPress.com VIP